Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Vaccinations for specific patient populations are provided separately, along with links to other COVID-19-related guidelines. (See "Society guideline links: COVID-19 – Index of guideline topics", section on 'Society guideline topics by medical specialty'.)
General guidance
●International
•WHO: COVID-19 vaccine checklist (2021)
•WHO: Injection safety in the context of coronavirus disease (COVID-19) vaccination (2021)
●Canada
•Public Health Agency of Canada (PHAC): Canadian Immunization Guide – COVID-19 vaccine (2024)
●United States
•Advisory Committee on Immunization Practices (ACIP): COVID-19 vaccine recommendations
●Europe
•ECDC: Interim public health considerations for the provision of additional COVID-19 vaccine doses (2021)
•ECDC: Rollout of COVID-19 vaccines in the EU/EEA – Challenges and good practice (2021)
•ECDC: COVID-19 vaccination and prioritization strategies in the EU/EEA (2020)
●United Kingdom
•National Health Service (NHS) England: COVID-19 vaccination programme – Guidance for hospital hubs
•NHS England: COVID-19 vaccination programme – Guidance for vaccination centres
•NHS England: COVID-19 vaccination programme – Primary care guidance
•UK Health Security Agency (UKHSA): The Green Book – Immunisation against infectious disease: Guidance on COVID-19 (2020, updated 2024)
●Australia
●Japan
•[In Japanese] Japanese Association for Infectious Diseases (JAID): Recommendations for COVID-19 vaccine (2023)
•[In Japanese] Ministry of Health, Labor, and Welfare (MHLW): Guidance on immunization practices related to the new coronavirus infection, 14th edition (2023)
•[In Japanese] National Institute for Infectious Diseases (NIID): About the new corona vaccine (2021)
Vaccine-specific guidance
●International
•WHO: Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19 (2022)
•WHO: Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN vaccine against COVID-19 (2022)
•WHO: Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 (2022)
•WHO: Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19 (2022)
●Canada
●United States
•Advisory Committee on Immunization Practices (ACIP): COVID-19 vaccine recommendations
Specific populations
●International
●United States
•Advisory Committee on Immunization Practices (ACIP): COVID-19 vaccine recommendations
•American Academy of Pediatrics (AAP): COVID-19 vaccines in children and adolescents (2022)
●Europe
•ECDC: Interim public health considerations for COVID-19 vaccination of children aged 5-11 years (2021)
●Japan
•[In Japanese] National Institute of Infectious Diseases (NIID): New corona vaccine that can be vaccinated in Japan – 12 years old and over (2023)
Adverse effects
Allergic reactions
●International
•World Allergy Organization (WAO): Statement on COVID-19 vaccine-associated anaphylaxis (2021)
●United States
•ACAAI: Guidance on risk of allergic reactions to COVID-19 vaccines (2021)
•ACAAI: Guidance on risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine (2020)
●Europe
●United Kingdom
•Resuscitation Council UK (RCUK): Anaphylaxis guidance for vaccination settings (2020, updated 2021)
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
●International
●Canada
•Thrombosis Canada: Vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) (2021)
●United States
•American Society of Hematology (ASH): Vaccine-induced immune thrombotic thrombocytopenia (2022)
●United Kingdom
•National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline – Vaccine-induced immune thrombocytopenia and thrombosis (VITT) (2021, updated 2022)
●Australia–New Zealand
•THANZ: Multidisciplinary VITT guideline for doctors (2021)
Other adverse effects
●Canada
●United States
Resources for patients — The following links provide resources about COVID-19 for non-clinicians. These resources come from select society and government-sponsored guidelines from several countries and regions around the world.
●[International] World Health Organization (WHO): Coronavirus disease (COVID-19) – Vaccines safety
●[Canada] Public Health Agency of Canada (PHAC): Vaccines for COVID-19
●[United States] Centers for Disease Control and Prevention (CDC): Vaccines for COVID-19
●[United Kingdom] National Health Service (NHS): Coronavirus (COVID-19) vaccination
●[Australia–New Zealand] Australian Government Department of Health (DOH): COVID-19 vaccines
●[Australia–New Zealand] New South Wales (NSW) Health: COVID-19 and flu vaccination in NSW
UpToDate also offers "The Basics" patient education pieces, which are written by the doctors and editors at UpToDate. These are written in plain language, at the 5th to 6th grade reading level, and answer the main questions a person is likely to have. (See "Patient education: COVID-19 overview (The Basics)" and "Patient education: COVID-19 and children (The Basics)" and "Patient education: COVID-19 and pregnancy (The Basics)" and "Patient education: COVID-19 vaccines (The Basics)".)
Do you want to add Medilib to your home screen?